Cardiology Advisor Institute Spotlight Course

Mitral Valve Disease: Role of Transcatheter Intervention for Optimal Lifetime Management

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s)

1.00 CME CE: Join three top experts in the field as they discuss the state-of-the-art in mitral valve repair and replacement. Exp 1/13/24

Additional Cardiology Courses

Digital Pathway – Changing the Treatment Paradigm for LDL-C Lowering Post-MI: The Case for Early, ‘High-Intensity Lipid Lowering Therapy’ to Improve Outcomes

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists, CPEU Credit

1.50 CME CE: Risk of a recurrent CV event post-MI is substantial. Targeted LDL-C optimization of lipid lowering therapy remains suboptimal. Exp 9/23/23

TAVR Update: Underutilization, Clinical Outcomes, Costs, and Future Directions

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s)

1.00 CME CE: Many patients who would benefit from transcatheter aortic valve replacement go untreated. Learn about cost-saving TAVR implementation. Exp 9/30/2023

Homozygous Familial Hypercholesterolemia: Improving Outcomes Through Timely Diagnosis and Treatment

AMA PRA Category 1 Credit(s)^TM, AANP Contact Hour(s)

1.00 CME CE: Homozygous Familial Hypercholesterolemia is rare, but clinicians in cardiology, primary care, and pediatrics can improve outcomes. Exp 10/31/23

Improving HoFH Outcomes: Strategies for Better Treatment and Reduced Barriers to Care

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s)

CME 1.00: Discusses diagnosing and treating HoFH patients and how to improve HoFH patient outcomes and quality of life. Exp 4/14/23

Mechanical Circulatory Support: Right, Left, and Biventricular

AMA PRA Category 1 Credit(s)^TM, ABIM MOC Points

1.00 CME: Right-Sided MCS with RA-PA Pump and Left-Sided MCS with LA-AO Pump. Emerging role of VA ECMO in cath lab and biventricular MCS. Exp 5/30/23

Optimizing Antiplatelet Therapy in Cardiogenic Shock

AMA PRA Category 1 Credit(s)^TM, ABIM MOC Points

1.00 CME: Pharmacokinetic/pharmacodynamic profile of parenteral antiplatelet agents and future antiplatelet and antithrombotic therapeutic targets. Exp 5/30/23

Better Weight Management, Better Outcomes: Practical Approaches to Managing the Interrelated Conditions of Obesity and PCOS

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s)

2.00 CME CE: This program is for clinicians interested in the treatment of PCOS and other women’s health challenges related to excess weight or obesity. 6/27/23

Cardiac Risk Stratification in Action

AMA PRA Category 1 Credit(s)^TM

In the third part of this CME series, faculty will discuss patient cases to assess hs-cTn testing as a prognostic tool for secondary and primary prevention.

Mitral Valve Disease: Role of Transcatheter Intervention for Optimal Lifetime Management

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s)

1.00 CME CE: Join three top experts in the field as they discuss the state-of-the-art in mitral valve repair and replacement. Exp 1/13/24

Part 2 of 2: Exploring Perspectives in Obesity Management: From Personal Experience to Best Practice

AMA PRA Category 1 Credit(s)^TM, CNE Contact Hour(s)

0.50 CME CE: This podcast will explore personal experiences from a person living with obesity, and what providers can do to overcome stigma associated with the disease. Exp 7/28/23

Digital Pathway – The Evolving Landscape of LDL-C Reduction in High-Risk Patients: Optimizing Combination Therapy to Reduce ASCVD Risk

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists, CPEU Credit

1.00 CME CE: Experts discuss the efficacy and safety of new approaches of LDL-C lowering therapy and current treatment options’ application to patient care. Exp 11/4/23

Anemia in Patients with CVD and CKD: Current Management and Potential Role of HIF-PHIs

AMA PRA Category 1 Credit(s)^TM, ABIM MOC Points

1.00 CME: Learn about the etiology of anemia in CKD, the effects on CV disease, and advantages and limitations of current management strategies. Exp 11/16/23